Connect with us
European Gaming Congress 2024

Artificial Intelligence

Liquid Biopsy Market to Grow at a CAGR of 19.7% during 2018 – 2028 | BlueWeave Consulting

Published

on

New Delhi, July 20, 2022 (GLOBE NEWSWIRE) — Global Liquid Biopsy Market is flourishing owing to the rising demand for non-invasive technology that detects molecular biomarkers using liquid samples instead of expensive or invasive procedures along with the advantages of liquid biopsy such as ease of use and minimal invasiveness, early cancer diagnosis and detection, characterization of new lesions, and identification of the drug and therapeutic targets for cancer treatment…

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Global Liquid Biopsy Market was worth USD 2.67 billion in the year 2021. The market is projected to grow at a CAGR of 19.7%, earning revenues of around USD 9.30 billion by the end of 2028. Global Liquid Biopsy Market is booming because of the expanding detection and isolation of circulating tumor DNA, exosomes, and circulating tumor cells. The rapid advancement of digital Polymerase Chain Reaction (PCR) and NGS-based technology has improved liquid biopsy accuracy. It can be used repeatedly to monitor disease progression and is expected to help overcome the limitations of tissue biopsies. Moreover, the constantly evolving pipeline of ctDNA-based liquid biopsy tests, an increasing number of commercialized products, and the potential of ctRNA in determining molecular profiles have all contributed to this segment’s dominance. Furthermore, Global Liquid Biopsy Market is one of the most emerging markets that grow continuously owing to the fast integration of new technologies such as the Internet of Things (IoT), Artificial Intelligence (AI), cloud computing, and others. However, high costs associated with R&D capabilities, limited infrastructural facilities, and lower sensitivity of certain liquid biopsies are expected to stymie market growth, in turn, may act as a huge restraining factor for the market growth.

Increasing technological progress

Surging demand for advanced diagnostic equipment, combined with an increase in the number of research laboratories in developing economies, is driving the market growth rate. Furthermore, the rising prevalence of blood cancer around the world is paving the way for market expansion. Moreover, rising R&D spending, particularly in developed and developing economies, will create more lucrative market growth opportunities for medical instruments and devices. The research and development capabilities of pharmaceutical and biopharmaceutical countries for the integration of advanced technologies in healthcare facilities are also boosting market growth rates. As a result, the Global Liquid Biopsy Market is predicted to develop at a significant rate during the forecast period (2022-2028).

 

Request for Sample Report @ https://www.blueweaveconsulting.com/report/liquid-biopsy-market/report-sample

Advertisement
Stake.com

Growing Advantages of Liquid Biopsy in the Healthcare Industry

In hospitals, clinics, pathology labs, and other healthcare and research facilities, liquid biopsy tests are conducted to comprehend the molecular elements of cancer. Liquid biopsy is a non-invasive method that uses liquid samples to discover molecular biomarkers without the use of pricy or intrusive procedures. Liquid biopsies provide some advantages that increase the safety and effectiveness of cancer therapy for patients, including their ease of use and low invasiveness, early cancer diagnosis and detection, characterization of new lesions, and discovery of drug & therapeutic targets. This results in offering lucrative opportunities for the Global Liquid Biopsy Market during the forecast period (2022-2028).

Challenge: Vague Reimbursement Situation

The procedure of paying for pricey molecular testing and the knowledge of the several specialists needed to interpret test results and create treatment programs are convoluted and uneven. This is particularly problematic with more expensive modern methods like liquid biopsy. The price of molecular testing services is frequently unknown to doctors, pathologists, and patients until they are paid or billed. Both patients and medical professionals find the confusion disturbing. Additionally, payers’ biomarker coverage policies have complex organizational structures that make them challenging to comprehend. While some only pay for the most fundamental tests or those related to certain clinical disorders and genes, others pay for a wide variety of testing. This wide range frequently makes assessing and tracking multiple coverage policies more difficult.

Segmental Coverage

Advertisement
Stake.com

Global Liquid Biopsy Market – By Circulating Biomarker

Based on circulating biomarkers, the Global Liquid Biopsy Market is segmented into Circulating Tumor Cells, Circulating Tumor DNA. The circulating tumor cells segment now has the biggest market share and is likely to continue to do so during the forecast period (2022-2028). This is due to the increased number of clinically important tests with genomic analyses in recent years. Furthermore, due to the rapid development of next-generation sequencing (NGS) technologies in liquid biopsy advancements applied to circulating tumor DNA, circulating tumor DNA is expected to be the fastest-growing segment during the forecast period (ctDNA).

Please Visit the Press Release of Global Liquid Biopsy Market: https://www.blueweaveconsulting.com/press-release/global-liquid-biopsy-market-to-grow-at-a-cagr-of-19-7-during-2018-2028

Global Liquid Biopsy Market – By Clinical Application

Based on clinical application, the Global Liquid Biopsy Market is segmented into Early Cancer Screening, Therapy Selection, Treatment Monitoring, and Recurrence Monitoring. Among these, cancer screening dominates the market. While screening consists of evaluating healthy individuals to find those who have cancer before any symptoms occur, early diagnosis focuses on identifying symptomatic patients as early as feasible. Moreover, therapy selection is expected to dominate the market share. Therapy selection tests are a type of liquid biopsy in which substrates isolated from bodily fluids such as blood, saliva, or urine are sequenced. This method is less invasive, can be used more frequently, and is less expensive than tests involving tissue sampling via invasive procedures such as surgery.

Advertisement
Stake.com

Impact of COVID-19 on Global Liquid Biopsy Market

The coronavirus disease (COVID-19) has spread worldwide. As a result of the increased number of Coronavirus patients, governments have imposed several rules and lockdowns around the world, affecting the market growth in the early stages of the forecast period. As a result, early detection programs have been halted. Furthermore, there has been a decrease in cancer screenings, visits, therapies, and surgeries, with variations by cancer type and location of service globally, resulting in an increase in cancer morbidity and mortality in 2020. The pandemic has also had an impact on the logistics and supply of cancer diagnostic raw materials and components, as well as other critical commodities used in the production of liquid biopsy. During the COVID-19 pandemic, these factors limit the growth of the liquid biopsy market.

Competitive Landscape

The leading market players in the Global Liquid Biopsy Market are F. Hoffmann-La Roche Ltd, Myraid Genetics, QIAGEN, Thermo Fisher Scientific Inc, Guardant Health, MDxHealth SA, Exact Sciences Corporation, Sysmex Inostics, Bio-Rad Laboratories, ANGLE plc, and other prominent players. The Global Liquid Biopsy Market is highly fragmented with the presence of several manufacturing companies in the country. The market leaders retain their supremacy by spending on research and development, incorporating cutting-edge technology into their goods, and releasing upgraded items for customers. Various tactics, including strategic alliances, agreements, mergers, and partnerships, are used.

Don’t miss the business opportunity in the Global Liquid Biopsy Market. Consult our analysts to gain crucial insights and facilitate your business growth.

Advertisement
Stake.com

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Liquid Biopsy Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Liquid Biopsy Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Recent Developments

  • In June 2021, Guardant Health, Inc. (US) launched its Guardant360 Response test that detects changes in circulating tumor DNA (ctDNA) levels.
  • In October 2020, F. Hoffmann-La Roche Ltd. (Switzerland) received the US FDA approval of expanded claims for the cobas EGFR Mutation Test v2 to be used as a companion diagnostic (CDx) for a broader group of therapies to treat non-small cell lung cancer (NSCLC).
  • In September 2020, Personalis, Inc. launched NeXT Liquid Biopsy, a high-performance, exome-scale, tumor-profiling platform that utilizes blood samples from advanced-stage solid tumor cancer patients.

 Scope of the Report

Attributes Details
Years Considered Historical data – 2018-2021
Base Year – 2021
Forecast – 2022 – 2028
Facts Covered Revenue in USD Billion
Product Service/Segmentation By Sampling Type, By Product and Service, By Circulating Biomarkers, By Clinical Application, By Application, By End-User, By Region.
Key Players F. Hoffmann-La Roche Ltd, Myraid Genetics, QIAGEN, Thermo Fisher Scientific Inc, Guardant Health, MDxHealth SA, Exact Sciences Corporation, Sysmex Inostics, Bio-Rad Laboratories, ANGLE plc, and other prominent players.

By Sampling Type

  • Blood Sampling
  • Urine Sampling
  • Saliva Sampling
  • Other Tissue Fluids Sampling

By Product and Service

  • Assay Kits
  • Instruments
  • Services

By Circulating Biomarker

  • Circulating Tumor Cells
  • Circulating Tumor DNA

By Clinical Application

  • Early Cancer Screening
  • Therapy Selection
  • Treatment Monitoring
  • Recurrence Monitoring

By Application

  • Cancer Applications
  • Non-Cancer Applications

By End User

  • Reference Laboratories
  • Hospitals
  • Physician Laboratories
  • Academic Researchers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Please Find Below Some Related Topics:

About Us 

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

Contact Us:

Advertisement
Stake.com

BlueWeave Consulting & Research Pvt. Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

[email protected]
https://www.blueweaveconsulting.com/

https://www.linkedin.com/company/blueweaveconsulting/

Advertisement
Stake.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

New Electric Mountain Bike Player Amflow Enters Market, unveiling its Revolutionary First Bike powered by DJI Avinox at Eurobike 2024

Published

on

new-electric-mountain-bike-player-amflow-enters-market,-unveiling-its-revolutionary-first-bike-powered-by-dji-avinox-at-eurobike-2024

Passionate Bikers and Tech Experts unite to combine a powerful and compact e-bike system into an ultra-light build, the Amflow PL
FRANKFURT, Germany, July 3, 2024 /PRNewswire/ — Amflow, the eMTB expert that builds e-bikes from heart to body, today marks its entry into the industry with the launch of the Amflow PL. Providing a significantly robust 850 W of peak power and weighing in at an industry leading level of ultra-light 19.2kg1, the Amflow PL provides riders with an unmatched combination of power, range, and performance, hidden in a sleek electric mountain bike appearance.

 
“As engineers with a passion for mountain biking, we have seen a lot of tech innovation that has never found its way into the eMTB scene,” said Peter Archer, Amflow Senior Product Specialist at Amflow. “We have married our tech expertise with our passion and today we’re introducing Amflow to the mountain biking community with our very first product, the Amflow PL. We believe this is a significant moment for the eMTB industry with innovative technology and ultra-light material combining to turn any terrain into a wonderland of possibilities for eMTB riders.”
Ultra-light Frame, Organic Design
The Amflow PL is a full-power eMTB with a stunningly lightweight body. The ultra-light carbon fibre frame weighs just 2.27kg1 and has been designed and expertly-crafted to deliver the ultimate ride, wherever the rider is headed.
Tackle Terrain with Confidence
At the heart of the Amflow PL is the DJI Avinox Drive System incorporating multiple cutting-edge technologies in both software and hardware design. The drive unit features a compound planetary gearset, providing industry-leading power-to-size ratio, with 105 Nm torque and peak power output of 850 W (nominal power output of 250 W) from a drive unit weighing just 2.52kg1.
The high-strength polymer gears inside the drive unit effectively suppress noise during high-speed gearbox operation. With multiple high-precision sensors built-in, combined with DJI’s advanced algorithms, it provides a strong and smooth assistance experience across a wide range of scenarios and conditions.
Preference Matching Assistance
In addition to traditional assistance modes, the DJI Avinox Drive System also features a specialized Auto mode, which adapts assistance in real-time based on road conditions and riding position1.  Once enabled, Auto mode empowers users to tackle a wide variety of terrain types and gradients without having to switch modes.
For the most challenging trails, Boost mode can be activated to instantly receive 120 Nm of torque and 1000 W high-power assistance1, enabling steep inclines to be tackled with ease.
Furthermore, Amflow PL has Walk mode which features intelligent walk assistance for easy incline traversing, Auto Hold to prevent rollback on slopes, and Hill Start Assist for additional torque to get riders started on inclines. It also allows stationary gear-shifting for a smooth and intuitive experience.
Fast Charging, High-Capacity Battery Offers Extended Range
The Avinox system’s battery weighs just 2.87kg1 and boasts an ultra-high energy density, ensuring an uncompromised range.
For those wanting to get back out there as soon as possible, a compact and convenient 12A/508W GaN fast charger1 is capable of charging the battery from 0% to 75% in just 1.5 hours1.
When it comes to battery life; real-time monitoring, self-discharge, active voltage reduction, and abnormality alerts, all feed into the battery health management system to create a durable and reliable battery that still maintains at least 80% capacity after 500 charge-discharge cycles1.
Agile and Responsive with Cutting-edge Geometry
The Amflow PL’s all-around frame design features cutting-edge geometry, offering balanced performance that’s both lightweight and hyper-agile. This stable yet agile handling empowers riders to easily take on rugged trails and more technical rides.
For those looking to adapt the wheel size to their needs, the Amflow PL frame structure is compatible with both 27.5″ and 29″ rear wheels1.  So, whether looking for a smoother ride with larger wheels or agility with smaller ones, a simple adjustment of the flip chip will allow for either size to be fitted without altering the frame’s geometric center of gravity.
Optimized Ride Efficiency
Featuring a four-bar linkage structure, the Amflow PL significantly reduces pedal kickback while greatly improving pedaling efficiency, ensuring that every pedal stroke counts.
Superior Suspension
The rear shock, co-tuned with FOX, offers a sensitive initial stroke response to effectively filter out minor vibrations. It also provides powerful end-stroke support to prevent bottom-outs during continuous high-speed impacts or steep descents, enabling riders to fully enjoy every off-road adventure.
Danny Tien, Asia Sales Manager at FOX said: “FOX has always been dedicated to pursuing better, which mirrors Amflow’s passion to create the ultimate riding experience. During our collaboration process, we were impressed by the enthusiasm and professionalism of the Amflow team. Whether as a business partner or an experienced bike user, we are excited to witness the birth of Amflow PL, an all-round electric mountain bike. The excellent handling experience brought by its ultra-lightweight and cutting-edge design cements our belief that the presence of Amflow will allow more cycling enthusiasts to enjoy the thrill of electric mountain biking.”
 Control at Your Fingertips
At the core of the DJI Avinox system is a 2″ full-color OLED touchscreen control display which is integrated directly into the frame of the Amflow PL. Riders are presented with a wealth of information including real-time riding data, estimated range and the ability to adjust the setup with just a swipe.
Even greater control can be gained by Bluetooth-enabled Wireless Controllers that connect wirelessly to the control display. Mode switches can be made while riding.
When connected to the Avinox App riders have access to;
Customizable Parameters: Parameters of riding modes can be quickly customized to adjust power, torque and cadence, according to riding habits.Anti-theft Mode1: A password-protected anti-theft mode will sound an alarm and the app will send a notification, if unauthorized movement of the eMTB is detected.Remote Locating: The bike’s real-time location can easily be checked.Comprehensive Data Recording, Easy Metric Sharing
With the control display or the Avinox app, riders can review rich data like speeds, range, cadence, power, torque, gradient, altitude, calories burned, ride times, heart rate, and more. This data can also be easily synced with third-party apps such as Strava to share with friends and the eMTB community. 
Thoroughly Tested for Optimum Reliability
Riders of the Amflow PL bike and users of the DJI Avinox Drive System components can be assured of the quality of the products as they have been certified by authoritative organizations such as TÜV SÜD, UL Solutions, and TÜV Rheinland1.
Additionally, Amflow has established a testing platform to conduct a wide variety of reliability tests for frame strength, waterproofing, and long-distance transportation under real-world riding conditions. This ensures product stability and safety in extreme environments, delivering comprehensive quality assurance.
Availability
Amflow products are estimated to be available by Q4 2024 through authorized dealers in Germany, the UK and Australia amongst others. This global service network provides customers with timely, efficient, and professional services, continuously safeguarding product quality.
For more information about Amflow and Amflow PL, please visit: https://www.amflowbikes.com/pl-carbon
About AmflowProudly born in 2023, Amflow is the creation of tech experts with a limitless passion for riding mountain bikes. The company strives to amaze with an unmatched combination of power, range, and performance, hidden in sleek electric mountain bike bodies. Amflow’s commitment to the e-bike industry is to make its e-mountain bikes the go-to for all e-bike riders looking to turn any terrain into a wonderland of possibilities. 
About DJISince 2006, DJI has led the world with civilian drone innovations that have empowered individuals to take flight for the first time, visionaries to turn their imagination into reality, and professionals to transform their work entirely. Today, DJI serves to build a better world by continuously promoting human advancement. With a solution-oriented mindset and genuine curiosity, DJI has expanded its ambitions into areas such as cycling, renewable energy, agriculture, public safety, surveying and mapping, and infrastructure inspection. In every application, DJI products deliver experiences that add value to lives around the world in more profound ways than ever before.
For more information, visit our:Website: https://www.amflowbikes.comFacebook: https://www.facebook.com/amflowbikes/Instagram: https://www.instagram.com/amflowbikesSubscribe to our YouTube Channel: https://www.youtube.com/@amflowbikes
1 All data was tested in controlled conditions. Actual experience may vary. For more details, please refer to the product page on the official Amflow website.
Photo – https://mma.prnewswire.com/media/2450854/image.jpg Photo – https://mma.prnewswire.com/media/2453451/Eurobike.jpg

View original content:https://www.prnewswire.co.uk/news-releases/new-electric-mountain-bike-player-amflow-enters-market-unveiling-its-revolutionary-first-bike-powered-by-dji-avinox-at-eurobike-2024-302188768.html

Continue Reading

Artificial Intelligence

Cell Impact adds sealing as a new part of production process

Published

on

cell-impact-adds-sealing-as-a-new-part-of-production-process

KARLSKOGA, Sweden, July 3, 2024 /PRNewswire/ — Cell Impact continues to develop its production process to better meet customer demand. The latest addition to the company’s production process is the opportunity to seal bipolar flow plates through dispersion.

Sealing is a critical part of the assembly of bipolar flow plates for fuel cells and electrolyzers.
“Together with our customers, we have evaluated various sealing processes over the past years with the ambition of adding this process to our production. Now, we are taking further steps to offer our customers a complete bipolar plate, ready to be assembled directly into their fuel cell and electrolysis stacks,” says Marcus Nilsson, Sales and Program Manager at Cell Impact.
Dispensing is one of the most popular sealing solutions used in the industry today.
“Dispensing offers both high precision and process flexibility and is thus suitable for our customers’ prototype and serial production products,” concludes Marcus Nilsson.
About Cell Impact
Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell and electrolyzer manufacturers. The company has developed and patented a unique method for high velocity forming, Cell Impact Forming™ which is significantly more scalable and cost-efficient compared to conventional forming methods. Cell Impact Forming is an environmentally friendly forming technology that consumes no water and very little electrical power.
The Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden AB is the company’s Certified Advisor (CA).
For more information, please contact:
Daniel VallinCEO and IR contact, Cell Impact AB (publ)+46730686620 or [email protected]

View original content:https://www.prnewswire.co.uk/news-releases/cell-impact-adds-sealing-as-a-new-part-of-production-process-302188763.html

Continue Reading

Artificial Intelligence

Flytxt included in the 2024 Gartner® Magic Quadrant™ for AI in CSP Customer and Business Operations

Published

on

flytxt-included-in-the-2024-gartner-magic-quadrant™-for-ai-in-csp-customer-and-business-operations

DUBAI, UAE and MUMBAI, India, July 3, 2024 /PRNewswire/ — Flytxt, a leading provider of AI SaaS solutions that maximise Customer Lifetime Value (CLTV) for subscription businesses, announced its inclusion as a niche player in the Gartner Magic Quadrant for AI for CSP Customer and Business Operations report.

Flytxt believes that inclusion in the report reflects their expertise in providing market-proven CLTV maximisation solutions for CSPs leveraging their specialised AI, which is developed and refined over 12 years, and trained with trillions of data points from the Industry.  The rapidly deployable AI SaaS solutions help CSPs optimise decisions and actions across customer engagement contexts, such as in marketing, customer care or product management, to drive better business outcomes. 
“We’re delighted to be included in the Gartner Magic Quadrant for AI in CSPs Customer and Business Operations report. We chose a productised approach to delivering AI solutions, driven by our vision that an AI that continuously learns from different customer engagement contexts and markets delivers vastly improved accuracy and faster ROI to clients” said, Dr. Vinod Vasudevan, CEO of Flytxt.
“Our AI solutions empower CSPs to gain deeper insights into product usage and customer behaviour throughout their lifecycle, helping them optimise opportunities to maximise customer and product lifetime value. They can review and refine existing product catalogs, launch new products and offers, predict future actions or needs of customers, improve digital adoption and retention, and enhance marketing and care efficiency, all leading to tangible business outcomes” he added. 
The efficiently-trained and ready-to-deploy AI for CX solutions from Flytxt offers superior accuracy, efficiency, user trust, and faster time to value compared to generic or custom AI solutions. Today, more than 75 CSP’s leverage Flytxt’s solutions to improve their customer experience journeys and maximise customer lifetime value. 
For more information about Flytxt and its CLTV maximization solutions, please visit www.flytxt.com.
Gartner, Magic Quadrant for AI in CSP Customer and Business Operations, By Pulkit Pandey, Amresh Nandan, Peter Liu, 4 June 2024.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Photo: https://mma.prnewswire.com/media/2452536/Gartner_MQ.jpgLogo: https://mma.prnewswire.com/media/2096851/Flytxt_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/flytxt-included-in-the-2024-gartner-magic-quadrant-for-ai-in-csp-customer-and-business-operations-302188669.html

Continue Reading
Advertisement
Stake.com
Advertisement

Latest News

Trending